This topic contains a solution. Click here to go to the answer

Author Question: Jean Piaget A) Studied abnormal behavior in children. B) Used high-constraint experimentation in ... (Read 68 times)

storky111

  • Hero Member
  • *****
  • Posts: 561
Jean Piaget
 
  A) Studied abnormal behavior in children.
  B) Used high-constraint experimentation in his research.
  C) Studied cognitive development in children.
  D) Studied the aging process in the elderly.

Question 2

In both case study and naturalistic research, the investigator
 
  A) Does not manipulate independent variables.
  B) Does not care about dependent variables.
  C) Manipulates independent variables.
  D) Manipulates dependent variables.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Yixagurpuldink

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

Answer: C

Answer to Question 2

Answer: A




storky111

  • Member
  • Posts: 561
Reply 2 on: Aug 4, 2018
Thanks for the timely response, appreciate it


billybob123

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library